Holen Sie sich die Stockscreener-App
1.08
9.00%
0.0892
Schlusskurs vom Vortag:
$0.9908
Offen:
$1
24-Stunden-Volumen:
98,505
Relative Volume:
1.43
Marktkapitalisierung:
$16.48M
Einnahmen:
$48.43M
Nettoeinkommen (Verlust:
$-11.04M
KGV:
-1.6119
EPS:
-0.67
Netto-Cashflow:
$-7.00M
1W Leistung:
+20.05%
1M Leistung:
-21.74%
6M Leistung:
-36.84%
1J Leistung:
-64.24%
1-Tages-Spanne:
$1.00
$1.10
1-Wochen-Bereich:
$0.8781
$1.10
52-Wochen-Spanne:
$0.782
$3.65
Iridex Corp Stock (IRIX) Company Profile
Firmenname
Iridex Corp
Sektor
Branche
Telefon
(650) 940-4700
Adresse
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Vergleichen Sie IRIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.08 | 16.48M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
131.57 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.40 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
373.52 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.49 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.96 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2017-11-03 | Fortgesetzt | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2016-01-26 | Eingeleitet | Singular Research | Buy |
| 2007-01-03 | Eingeleitet | First Albany | Buy |
Iridex Corp Aktie (IRIX) Neueste Nachrichten
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
IRIDEX Corporation (NASDAQ:IRIX) Q4 2024 Earnings Call Transcript - MSN
Iridex: Q4 Earnings Snapshot - MySA
IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic Investments and Revenue Growth ... - Yahoo Finance UK
IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic I - GuruFocus
Iridex Corporation Reports Improved Financial Performance - TipRanks
IRIDEX earnings matched, revenue fell short of estimates - Investing.com
Earnings call transcript: IRIDEX Q4 2024 sees aftermarket stock surge - Investing.com
IRIDEX Corp Q4 2024 Earnings: EPS Meets Estimate at -$0.05, Reve - GuruFocus
IRIDEX Earnings Results: $IRIX Reports Quarterly Earnings - Nasdaq
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance
Earnings Preview For Iridex - Benzinga
IRIDEX (NASDAQ:IRIX) Shares Cross Below 200-Day Moving Average – Should You Sell? - Defense World
IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Iridex secures $10 million investment for growth initiatives By Investing.com - Investing.com
Iridex Corporation Closes $10 Million Strategic Investment with Novel Inspiration International Co., Ltd. - Nasdaq
Iridex Announces Strategic Investment in the Company - Yahoo Finance
Iridex Stock: Volatility Persists Amid Stable Fundamentals - Sharewise
Iridex addresses recent stock volatility - Investing.com
Iridex Comments on Recent Stock Price Volatility - Yahoo Finance
Iridex Corporation to Announce Q4 and Full Year 2024 Financial Results on March 27, 2025 - Nasdaq
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 - GlobeNewswire Inc.
Medical Laser Leader Iridex Sets Critical Year-End Earnings Report Date - StockTitan
IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com - Defense World
StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Iridex reports steady Q4 sales, eyes profitability in 2025 - Investing.com
Iridex Reports Mixed Q4 Results: Revenue Up, Achieves Positive EBITDA Amid Strategic Review - StockTitan
IRIDEX (NASDAQ:IRIX) Stock Passes Below 200 Day Moving Average – Time to Sell? - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management - Yahoo Finance
Iridex Announces Milestone Five-Year Study Confirms the - GlobeNewswire
Medical Lasers Market Focused Insights 2024-2029: Mergers, - GlobeNewswire
Veterinary Eye Care Market to Grow by USD 1.05 Billion (2024-2028), Report on AI-Powered Market Evolution and Rising Pet OwnershipTechnavio - The Malaysian Reserve
United States Retinal Surgery Devices Market - GlobeNewswire
IRIX Stock Surges Over 6% Amidst Medical Device Sector Decline - GuruFocus.com
Advancing Healthcare Tech: Medical Lasers Market Report 2024 - WhaTech
IRIDEX Corporation (NASDAQ:IRIX) Q3 2024 Earnings Call Transcript - MSN
Iridex's Glaucoma Treatment Exempt from New Medicare Reimbursement Limits | IRIX Stock News - StockTitan
IRIDEX Corp adjusts executive compensation, reshuffles board By Investing.com - Investing.com Australia
IRIDEX Corp adjusts executive compensation, reshuffles board - Investing.com India
3 US Penny Stocks With Market Caps Under $50M To Watch - Yahoo Finance
IRIDEX earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic M - GuruFocus.com
IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ... - Yahoo Finance
Iridex: Q3 Earnings Snapshot - The Washington Post
Finanzdaten der Iridex Corp-Aktie (IRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):